lobbying_activities: 3014388

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3014388	16b858f6-4220-44c7-98a6-9f74a4877546	Q2	AMERICAN VETERINARY MEDICAL ASSOCIATION	3630	AMERICAN VETERINARY MEDICAL ASSOCIATION	2023	second_quarter	PHA	H.R. 1418/ S. 1844 Animal Drug User Fee Act/ Animal Generic Drug User Fee Act reauthorization H.R. 1839/S. 993 Combatting Illicit Xylazine Act Review of Food and Drug Administrations Final Guidance for industry #256: Compounding Animal Drugs from Bulk Drug Substances- H.R. 1683 Generic Animal Drug Advancement Act, all provisions	Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE		330000	0	0	2023-07-19T11:17:12-04:00